21/11/2025
Extrapulmonary neuroendocrine carcinoma (epNEC) is a rare and aggressive subgroup of neuroendocrine carcinomas (NECs) occurring in multiple organs outside of the lung. With limited treatment options and a challenging prognosis, the median survival is just 7.7 months.
Our dedicated research efforts aim to transform this narrative and improve patient outcomes.
Discover more about ongoing initiatives and advancements in understanding epNEC: https://go.boehringer.com/rF1OC